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Abstract 
Background: The butanol fractionated root extract of Asparagus africanus Lam., a traditional herb widely used 
to treat various ailments were analyzed for the presence of potential toxicity after single (acute) and repeated 
(subchronic) dose oral administration in adult swiss albino mice using gavages.
Methods: For the acute study, butanol fractionated extract of the plant was administered in single doses of 1000, 
3000 and 5000 mg/kg body weight. In the sub-chronic dose study, the extract was administered at doses of 300 and 
600 mg/kg body weight/day for 42 days. Selected hematological and biochemical parameters of the blood followed 
by histopathological analysis were investigated after 42 days of daily administrations. The results were expressed 
as M ± SE, and differences at P < 0.05 was considered significant. One way analysis of variance (ANOVA) and least 
significant difference tests were employed to check the significant differences between the various parameters of the 
experimental groups.
Results: In the acute study, the extract did not caused dose-dependent general behavioral adverse effects, body 
weight change and mortality. The single dose toxicity studies therefore showed that the butanol fraction of the 
extract has high safety profile when given orally. After 42 days of daily dosing, in the sub-chronic study, no clinically 
significant changes were observed for hematological and biochemical parameters. Except an occasional small num-
ber of focal mononuclear lymphocytic cells infiltrations around the central and portal triad of the liver of a few mice, 
the histopathological parameters do not show significant change.
Conclusion: It is concluded that, the butanol fractionated extract from A. africanus at the given dose does not show 
significant toxicity. The presence of focal inflammation on the liver of a few mice may be associated to the presence of 
flavonoid glycoside in the butanol fractionated extract.
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Background
Many plants have shown very effective medicinal values 
for various ailments of human and domestic animals. 
Studies have witnessed several of the pharmaceuticals 
currently available to physicians have a long history of 
use as herbal remedies. Digoxin and digitoxin, drug for 
heart failure and atrial dysrhythmias, from digitalis leaves 
[27]; quinine, antimalarial drug, from cinchona bark [19] 
and anti-cancer compound bruceatin, from the ethiopian 
plant, Brucea antidysentrica [14], are examples of the 
contributions of traditional pharmacopoeia.
Despite its being natural, reputation and continued 
use over many centuries, recent studies on laboratory 
animals have shown many plants used as medicinal 
activity have potential toxicity on blood parameters and 
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histopathology of internal organs [5, 7, 18]. In addition, 
the advancement of technology has enabled to detect 
minute amounts of carcinogenic and toxic chemicals and 
recognize potentially hazardous effects of some of the 
herbs used in traditional medicines [25].
It therefore appears that, although traditional medicine 
is widely used to treat various diseases and often more 
available and affordable than modern medicine, it is not 
without limitations. Asparagus africanus Lam., com-
monly known with its vernacular name “Seriti” (Afaan 
Oromo) is one of the most effective medicinal plants 
widely used to treat malaria [10], impotency [29], diar-
rhea [1], lishmaniansis, bilharziasis, syphilis and gonor-
rhoea [26] and fertility [15]. The plant belongs to family 
Asparagaceae which includes 300 species in the genus 
Asparagus, widely distributed throughout Africa. It is 
a perennial shrub or climber with stems up to 6 m high 
growing between 700 and 3800  m above sea level [11, 
17]. Different studies have shown antimalarial activity 
of the plant with different potential of parasitimal sup-
pression. The crude extracts of A. africanus for instant 
have shown a parasitimial suppression of 46.1  % (root 
parts) and 40.7 % (aerial parts) on Swiss albino mice [12]. 
The methanol extracts of the plant found to have para-
sitaemia suppression against Plasomodium berghei at a 
dose of 200  mg/kg [12]. Butanol fractionated extract of 
A. africanus showed the highest inhibition (85.94  %) of 
P. berghei parasitaemia in the swiss albino mice [10]. In 
spite of such widespread use of the plant, its safety based 
on their effective dose is not yet known.
With the problems of increasing drug resistance and 
difficulties in getting affordable effective antimalarial 
drugs, traditional medicines, mainly of plant sources 
could be an important and sustainable ways of treatment 
if supported by clinical evidences of safety and efficacy. 
Medicinal plants not only complement modern medi-
cine but also are the basis for the development of mod-
ern pharmaceuticals. Despite highest (85.94 %) inhibition 
of P. bergei parasitaemia, no clinical evidence of safety 
(toxicity) yet found on butanol fractionated extract of A. 
africanus. This study is therefore aimed to investigate the 
toxicity of butanol fractionated extract of A. africanus 
Lam., on some blood parameters and histopathology of 
liver and kidney in mice.
Methods
Plant material collection and processing
The fresh root of A. africanus were collected from the 
border of Shashamane and Awassa towns about 270 km 
south of Addis Ababa. The plant was identified by a tax-
onomist in the Traditional and Modern Medicine Drug 
Research Directorate (formerly called Ethiopian Public 
Health Institute) at the Ethiopian Public Health Institute 
(formerly called Ethiopian Health and Nutrition Research 
Institute). A sample of the plant was deposited at the 
Herbarium of Traditional and Modern Medicine Drug 
Research Directorate with Voucher Specimen number 
Herb No. AA-2163. The collected plant roots were cut 
into pieces, cleaned from extraneous materials and then 
dried at ambient temperature (23–26  °C) and grounded 
to powder using a sample mill.
Hydro‑alcoholic extraction of the plant material
In this study both the hydro-alcoholic extract and sol-
vent fractionation of the plant material were done as 
the method employed on efficacy study by Debebe [10]. 
Briefly, hydro-alcoholic extract yields were obtained 
by soaking 400 g of plant powder in 3 L of 70 % ethanol 
to fully immerse and wet the plant powder. These were 
placed on orbital shaker rotating 120  rpm for 48  h for 
regular infusion. On the 3rd  day, the mixture was left 
to settle and the clear decanted supernatant was filtered 
using Whatman filter paper No. 3, 18.5  cm, England 
into a clean container. The extract was then reduced 
to dryness under low pressure using a rotary vacuum 
evaporator (BUCHI type R-205, with Aspirator pump, 
Switzerland) at a temperature of 40  °C rotating 40  rpm. 
Finally the filtrate in a container was put in a water bath 
(BUCHI Heating Bath B-490) to remove all the alcohol 
left in the extract. The crude extract was then stored in 
labeled sterile glass vials at −20 °C until used.
Solvent–solvent fractionation of plant material
The butanol fractions were obtained after the hydro-
alcoholic extract were exhaustively defatted respectively 
with n-hexane (6 repeat) and chloroform (8 repeat) 
respectively. The aqueous residue after de-fat was further 
partitioned with 50 ml of n-butanol for eight exhaustive 
separate and successive mixing and filtrations steps. The 
n-butanol fractionates were then combined, concen-
trated and labeled as butanol fraction (BF). The weight in 
the dry extract was expressed as total mass of the powder.
Experimental animal preparation
The study was conducted on Swiss albino mice (weigh-
ing 20–25  g) obtained from colonies in the animal unit 
of the Ethiopian Public Health Institute. The animals 
were acclimatized to laboratory conditions in the Tradi-
tional and Modern Medicine Drug Research Directorate 
for 1 week prior to the experimental procedure to mini-
mize any nonspecific stress. After a week, body weight 
of each mouse was measured in gram and recorded as 
the initial body weight. The mice were housed in stand-
ard aluminum cages maintained at normal laboratory 
conditions of temperature (21 ± 2 °C), relative humidity 
of 65 ± 0.5 % and 12 h light–dark cycle with free access 
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to standard commercial diets and clean tap water ad-
labium until the end of the experiment based on WHO 
Annex II Research guidelines for evaluating the safety 
and efficacy of herbal medicines [30].
Ethical clearance
Ethical approval for the animal used for this study was 
obtained from Addis Ababa University Medical Faculty 
Institutional Review Board Protocol number: 158/09/Anat.
Single dose toxicity study
The single dose study was carried out in 24 adult female 
mice randomly distributed into four groups (group I, II, 
III and IV), each with six mice. The plant extract was 
orally administered to the mice in groups I, II and III 
respectively, in a single dose of 1000, 3000 and 5000 mg/
kg body weight, while distilled water was administered 
to control group (group IV) using a stomach tube gav-
ages based on WHO Annex II; research guidelines for 
evaluating the safety and efficacy of herbal medicines 
[30]. Changes like muscular weakness, behavior change, 
salivation, diarrhea, body weight and food intake in com-
parison to the controls, were recorded separately for each 
animal for 14 days.
Repeated dose toxicity study
Selection of dose and duration of dosing
Effective dose for parasitimal suppression 300  mg/kg 
body weight [10] and its double (i.e., 600  mg/kg body 
weight) were selected for repeated dose toxicological 
investigation of the plant extract as the appropriate doses 
for this particular study for 42 days [30].
Administration of the extract
For repeated dose toxicity study, 36 mice were ran-
domly distributed into three groups, each with 12 mice 
and were assigned as group I, II and III. group I and II 
were respectively treated with 300 and 600 mg/kg body 
weight, while mice in group III were treated with vehi-
cle (distilled water) [30]. Administrations of the extract as 
well as the vehicle into the mice were done orally by using 
stomach tube gavages [30].
Hematological and biochemical parameters 
and histopathology of liver and kidney
After 24 h of the administration of the extract for the last 
time, i.e., at the end of the 6th week, the animals were 
anaesthetized under diethyl ether and blood sample for 
bioassays was immediately collected from each mouse 
by a cardiac puncture using sterile needle and syringe 
for evaluation of any change in hematological and bio-
chemical parameters [30]. Following collection of blood 
sample, tissue section from liver and kidney of all mice 
in each groups were immediately removed and processed 
for section preparation for light microscopy (fixed, dehy-
drated, cleared, impregnated, sectioned and placed in 
microscopic slides) and stained with Hrris hematoxylin 
and counterstained in 1 % alcoholic eosin for microscopic 
slides. At the end of every week, change in body weight 
was analyzed by recording the body weight of each 
animal.
Statistical analysis
All data were packed and analyzed by SPSS statistical 
Microsoftware. Mean values (M) and standard errors 
(SE) of the parameters were calculated and the results 
were expressed as M  ±  SE. One way analysis of vari-
ance (ANOVA) and least significant difference tests were 
employed to check the significant differences between the 
various parameters of the experimental groups. In addi-
tion, Dunnett t-tests which treat one group as a control, 
and compare all other groups against it was employed 
to compare the values within a parameter and to evalu-
ate the relationship between the variables. Differences at 
P < 0.05 was considered significant.
Results
Effect of single dose treatment of the butanol fractionated 
extract of Asparagus africanus
Following a single treatment with fractionated extract of 
A. africanus at doses of 1000, 3000 and 5000 mg/kg body 
weight, no signs and symptoms of toxicity on behav-
ior nor death were observed throughout the 14  days of 
the study period. Comparison of body growth patterns 
and body weight gains between the test groups and the 
control showed no significant differences as shown in 
Table 1.
Effect of repeated dose treatment of the fraction 
of Asparagus africanus
Effects of the fraction on hematological parameters of blood
No statistical significant (at P  >  0.05) change was 
observed in the hematological parameters of the mice 
treated with the repeated doses of 300 and 600  mg/kg 
body weight/day of the fractionated extracts of A. afri-
canus as compared to the controls as shown in Table 2. 
However, a non-significant increase in WBC in both 
groups, decrease in platelet count in mice treated with 
600 mg/kg and increase in mice treated with 300 mg/kg 
were seen as compared to the control.
Effects of the fraction on biochemical parameters of the 
blood
Values of the functional tests for liver (AST, ALP and 
ALT) and kidney (urea and creatinine) in the extract 
treated mice as compared to those of the controls are 
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shown in Table 3. All these values of the functional test 
showed no significant change.
Effect of the fraction on behavior and body weight
Daily cage-side observations did not reveal any physi-
cal changes in the skin, fur, eyes, and respiratory system 
and general behavioral patterns. No autonomic effect 
such as salivation, diarrhea and urination were observed 
throughout the 42 days of administration period as com-
pared to the controls. All of the treated as well as control 
mice survived until the scheduled necropsy. Macroscopic 
autopsy examination also did not reveal any pathological 
findings in the liver and kidneys. Comparable increase 
in body weight gains were observed for all the extract as 
well as the control mice as shown in Table 4.
Effect of the fraction on the histology of the liver
Microscopic examination of tissue sections of liver under 
light microscope from mice treated with the butanol 
fractionated extract of A. africanus at 300 and 600  mg/
kg body weight/day doses showed no treatment related 
pathological findings and were comparable to those of 
the controls. However, there were occasional focal mono-
nuclear lymphocytic cellular infiltration around the por-
tal and central vein of few slides as shown in Fig. 1a–d.
Effect of the fraction on histology of the kidney
Microscopic examinations of tissue sections of the kidney 
from the butanol fractionated extract treated mice at 600 
and 300  mg/kg body weight/day doses showed normal 
histology with no evident of treatment related changes as 
compared to those of controls Fig. 2.
Discussion
In this study, to determine the LD50, the butanol frac-
tionated extract with a minimum dose of 1000 and a 
maximum dose of 3000  mg/kg body weight were first 
tried in a single administration. As recommended by 
WHO guide line for dose selection, the dose was then 
raised to 5000 mg/kg body weight. In all the three doses, 
the mice treated with extract did not show change in food 
consumption, behavioral patterns, body temperature, and 
respiratory rate. No autonomic effects such as salivation, 
diarrhea and urination were seen. There were compara-
ble body weight gains among the extract treated mice as 
compared to those of the controls. All the treated mice 
survived until the scheduled necropsy. This finding there-
fore, suggested that the LD50 of the fractionated extract 
appears to be greater than 5000  mg/kg body weight. 
Hence, the single dose administration of the extract has 
high safety profile when given orally.
Table 1 Comparison of body weight change among butanol fractionated extract of A. africanus treated groups, at doses 
of 1000, 3000 and 5000 mg/kg body weight and control mice during the 14 days of observation
Data are expressed as mean ± SEM, n = 6/group
Group Dose (mg/kg) Initial body weight Body weight at day 7 Final body weight at day 14
III 1000 20.84 ± 0.80 27.62 ± 0.40 30.46 ± 0.45
II 3000 20.83 ± 0.35 27.57 ± 0.70 30.13 ± 0.48
I 5000 21.43 ± 0.54 27.94 ± 0.71 30.90 ± 0.69
IV Control 20.66 ± 0.44 26.90 ± 0.68 30.07 ± 0.45
Table 2 Comparison of  hematological parameters among  fractionated extract of  A. africanus treated groups at  doses 
of 300 and 600 mg/kg body weight/day, and the control mice




Control 300 mg/kg bwt 600 mg/kg bwt
Values % of mean  
difference
P value Values % of mean  
difference
P value
RBC (×106/µL) 10.93 ± 0.38 11.48 ± 0.46 4.79 0.596 11.33 ± 0.64 3.55 0.468
Hemoglobin (g/dL) 15.63 ± 0.75 16.47 ± 0.58 5.10 0.383 16.57 ± 0.75 5.67 0.433
Hematocrit (%) 56.97 ± 1.72 60.20 ± 2.29 5.37 0.756 56.05 ± 1.91 −1.61 0.294
MCV (fL) 52.17 ± 0.63 52.47 ± 1.27 0.57 0.662 52.83 ± 1.07 1.25 0.843
MCH (pg) 14.30 ± 0.21 14.33 ± 0.29 0.21 0.309 14.70 ± 0.27 2.72 0.929
MCHC (g/dL) 27.40 ± 0.59 27.37 ± 0.15 −0.11 0.593 27.80 ± 0.63 1.44 0.964
PLAT (103/µL) 581.00 ± 38.2 702.67 ± 99.3 35.56 0.564 455.33 ± 288.7 −21.67 0.169
WBC (103/µL) 4.76 ± 1.42 6.76 ± 2.36 29.59 0.352 7.97 ± 2.76 40.28 0.553
Page 5 of 9Kebede et al. BMC Res Notes  (2016) 9:49 
Analysis of red blood cell indices (Table 2) showed no 
significant reduction following repeated administra-
tion of the butanol fractionated extract of A. africanus. 
This result indicates neither lysis nor inhibition in blood 
cells synthesis by any of the active constituents that may 
exist in fractionated extract of A. africanus. The unlike-
lihood of the extract to induce anemia even after long 
use on red blood cell indices may be due to the inability 
of the extract to distract the matured red blood cell and 
inhibit erythropoiesis. This is in agreement with other 
related studies like the long term treatment with Teu-
crium polium total extract and its failure to induce any 
toxic effect on the matured red blood cells and hence was 
suggested to induce no anemia [16]. On the other hand, 
chronic treatments with plants extract like S. lycoper-
sicum, M. perennis, M. annua, E. balsamifera, E. hirta, 
E. heterophylla, E. lateriflora, E. hyssopifolia and Cassia 
italica are known to cause destruction of hematological 
parameters leading to anemia in animals [3, 4, 20].
Leukocytes are known to increase sharply as the first 
line defense of the body or in response to toxic environ-
ment when infection occurs. The absence of significant 
increase in the WBC after 42 days of chronic treatment 
with the extract suggests for lack of damaging toxic effect 
of the plant extract on the mice. The non-significant 
increases of the treated mice at P < 0.05 observed in the 
WBC count by 29.59 % and 40.28 %, respectively for 300 
and 600  mg/kg/body weight doses as compared to the 
control may probably be due to the normal responses 
of the mice to foreign bodies or stress associated with 
the sub-chronic toxicity of the extract. It is known that 
chronic treatment with some plant extract cause a non 
significant increase in WBC parameter as a normal 
response to the extract [2, 21].
Significant elevation of platelets (thrombocytosis) 
could predispose to hypercoagulable state, which results 
to spontaneous intravascular clotting and thromboembo-
lism that may lead to stroke and heart attack [6, 7]. On 
the other hand, significant decrease in platelets (throm-
bocytopaenia) could increase the tendency to bleed and 
have anticoagulant property [9]. In this study, the obser-
vation that platelets count was not affected significantly 
at any of the dose employed suggests that the fraction 
does not interfere with coagulation.
Generally, following exposure to a toxic substance, a 
significant reduction in body weight by more than 10 % 
from the initial body weight is a simple and sensitive 
index of toxicity [28]. In this study administration of the 
extract of A. africanus for 42 days at both of the investi-
gated doses, apart from slight variation, did not produce 
Table 3 Comparison of  biochemical parameters among  fractionated extract of  A. africanus treated groups, at  doses 
of 300 and 600 mg/kg body weight/day, and the control mice
Data are expressed as Mean ± SEM, n = 12
Biochemical 
parameters
Control 300 mg/kg bwt 600 mg/kg bwt
Value % of mean  
difference





208.17 ± 44.84 208.17 ± 51.63 0 1.00 261.20 ± 32.38 17.06 0.49
ALP
(IU/L)
74.00 ± 29.46 75.00 ± 10.25 1.33 0.34 76.32 ± 31.45 3.03 0.25
ALT
(IU/L)
107.50 ± 34.88 84.67 ± 9.64 −21.24 0.47 82.80 ± 13.41 −25 0.40
Urea
(mg/dL)
49.00 ± 2.91 52.33 ± 6.92 6.36 0.60 46.40 ± 1.33 −6.47 0.62
Creatnine (mg/
dL)
0.88 ± 0.11 0.83 ± 0.11 −5.68 0.75 1.24 ± 0.16 26.67 0.08
Table 4 Comparison of body weight change among fractionated extract of A. africanus treated groups, at doses of 300 
and 600 mg/kg body weight/day, and the control mice
Values are expressed as mean ± SEM; n = 12














G1 135.23 ± 2.31 144.18 ± 8.76 148.79 ± 11.79 156.28 ± 14.88 158.05 ± 32.20 154.93 ± 27.53 179.73 ± 16.17
G2 135.82 ± 1.37 158.97 ± 16.62 161.23 ± 16.12 162.81 ± 13.54 176.86 ± 15.29 173.11 ± 8.67 184.93 ± 13.33
G3 135.63 ± 3.52 162.29 ± 16.81 166.42 ± 18.99 171.05 ± 20.35 180.33 ± 27.41 180.01 ± 23.02 193.46 ± 21.56
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Fig. 1 Photomicrograph of section of mice Liver after 42 days of treatment with butanol fractionated extract of A. africanus at 600 mg/kg body 
weight/day (a, c) and 300 mg/kg body weight/day (b, d) as compared to the control (e, f). Peri-portal vein focal mononuclear lymphocytic cell 
infiltration around both portal and central veins of the treated mice, and those infiltrations are more around the central veins (sections were stained 
with H&E, ×2000)
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significant change in the body weight as compared to the 
controls. The slight non-significant differences observed 
may have resulted from physiological variations in the 
mice such as food intake and metabolism as suggested 
in other related study [22]. The lack of adverse effect of 
the plant on body weight is thus a pointer to the safety of 
prolonged oral administration of the butanol fractionated 
extract of A. africanus.
After treatment of the butanol fractionated extract 
at doses of 600  mg/kg body weight there were trends 
of increment in AST by 17.06 % and decrement in ALT 
by 25  % as compared to the control. However, as these 
were not statistically significant such changes appear not 
to be extract related. In a comparable study after admin-
istration of Glinus lotoides and Hagenia abyssinica the 
level of ALT decreased and the level of AST increased 
non-significantly and the author concluded that the 
extract is not hepatotoxic [23]. Moreover, after sub 
chronic treatment with butanol fractionated extract of A. 
Africanus at both doses the level of ALP did not change 
significantly as compared to the control suggesting the 
extract is not toxic to the liver or damaging to the integ-
rity of the bile duct.
Investigation for the toxic potential of a chemical is 
incomplete without gross and histopathological evalu-
ation [8]. Following exposure to a toxic substance, a 
significant reduction in body weight by more than 10 % 
from the initial body weight is a simple and sensitive 
index of toxicity [28]. The non significant differences 
between the weight of mice in the experimental and 
control group observed in this study may have resulted 
from physiological variations in the mice such as food 
Fig. 2 Photomicrographs of section of the mice kidney of 600 mg/kg body weight/day dose extract treated mice (a) and 300 mg/kg body weight/
day (b), as compared to the vehicle treated control mice (c). Sections were stained with H&E, ×2000 for a–c
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intake and metabolism as suggested in other related 
study [22].
Kidneys are particularly vulnerable to toxic agents 
given their high rate of perfusion by blood and their 
ability to concentrate a range of substances in the tubu-
lar lumen. Following administration of the butanol frac-
tionated extract, a non-significant increase by 5.68 and 
decrease by 26.67  % of kidney biochemical marker cre-
atinine was seen in mice treated respectively with 300 
and 600  mg/kg body weight/day. Furthermore, the urea 
level increased non significantly by 6.37  % for mice 
treated with 300 mg/kg and decreased non significant by 
6.47 % for mice treated with 600 mg/kg as compared to 
the control group. The current finding may suggest that 
the activity of protein metabolism was maintained within 
the normal range due to relatively non-toxic effect of the 
extract. Similar suggestion was made after non significant 
changes in creatinine and urea levels were seen follow-
ing repeated administration of Sphenocentrum jollyanum 
extract [24]. Hence the present result probably suggests 
for absence of any functional damage to the kidney show-
ing the extract did not interfere with the renal capacity to 
excrete the metabolites.
In the histo-pathological analysis of liver, apart from 
an occasional small number of focal mononuclear lym-
phocytic cells infiltration around the central and portal 
triad no gross or microscopic lesions were found follow-
ing the 42 days of administration of the extract at 300 and 
600  mg/kg body weight/day doses as compared to the 
controls. Hence, in this study the extract from A. Afri-
canus appears to be not nephrotoxic at 300 and 600 mg/
kg body weight/day doses studied as they did not show 
any gross or microscopic lesions. The focal mononuclear 
lymphocytic cell infiltration observed may be because of 
the flavonoid glycoside present in the A. africanus. How-
ever, this should be ascertained by phytochemical screen-
ing of A. africanus. The presence of glycosides on the 
other hand has been suggested to cause focal inflamma-
tion around the portal triad on the liver with no effect on 
the kidney [13].
The hematological and biochemical parameters of 
mice treated with the extract in repeated dose toxicity 
study showed no significant change as compared to the 
control mice. Lack of such statistically significant effect 
may be due to the absences of toxic secondary metabo-
lites in the butanol fractionated extract of A. africanus. 
The non-significant change in biochemical parameters on 
the other hand tells no tissue damage due to the adminis-
tration of the extract at 300 and 600 mg/kg/body/weight 
doses in mice. Indeed, such observation in the bio-
chemical parameter is in agreement with the histopatho-
logical findings in which no dose related tissue damage 
appeared, except for the presence of focal mononuclear 
lymphocytic cell infiltrations around the central vein and 
portal triad of few mice.
Conclusion
The present study revealed that the butanol fraction-
ated extract from the root of A. Africanus is not hepato-
nephro- and hemato-toxic at 300 and 600  mg/kg body 
weight/day as shown from body weight, biochemical, 
hematological and histopathological findings. As found 
from the present study A. Africanus is non-toxic at the 
studied dose in mice and this may call for further inves-
tigations including phytochemical screening as well as 
trial in other animals towards the development of drug 
from A. Africanus for its claimed traditional therapeutic 
values.
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